Projects

Find all JCSMR research projects.

Projects Open to Honours for Semester 1 2022

Projects Open to Honours for Semester 1 2022 »

Learn about the Honours projects available at JCSMR.

Group

Projects	Groups	Status
Phospholipid transport and B cell development	The Enders Group - Models of human primary immunodeficiencies	Current
Understanding B cell development - The role of SPPL2A on B cell survival	The Enders Group - Models of human primary immunodeficiencies	Current
Modelling human primary immune deficiences in mice	The Enders Group - Models of human primary immunodeficiencies	Current
Neutrophils and their extracellular traps in MS pathology	The Bruestle Group - Neuroimmunology and Multiple Sclerosis The Parish Group - Cancer & Vascular Biology	Current
Migration, effector function and transcriptional regulation of Th17	The Bruestle Group - Neuroimmunology and Multiple Sclerosis	Current
Identification and analysis of platelet polymorphisms associated with malaria susceptibility	The McMorran Group - Genetics and Infectious Diseases	Potential
Studying the interaction between genes and environment in Indigenous Kidney Disease	The McMorran Group - Genetics and Infectious Diseases	Potential
Host red enzymes as targets for host-directed antimalarial therapy	The McMorran Group - Genetics and Infectious Diseases	Potential
The role of platelets in the protection against malarial infection	The McMorran Group - Genetics and Infectious Diseases	Potential
Development of CRISPR/Cas9 genome editing technology	The Burgio Group - Genome editing and microbial immunity	Potential
RNA polymerase I inhibitors as therapeutics for cancer: analysis of p53 -dependent and – independent cell cycle checkpoints	The Hannan Group - Cancer Therapeutics	Current
Investigating how pertubations in ribosome biogenesis and the nucleolar surveillance response modulate cellular growth	The George Group - Pharmacogenomic Technologies The Hannan Group - Cancer Therapeutics	Current
Regulation of chromatin remodeling of the rRNA genes in mouse embryonic stem cells	The Hannan Group - Cancer Therapeutics	Current
RNA polymerase I inhibitors as therapeutics for cancer: Testing combination therapies for haematologic malignancies	The Hannan Group - Cancer Therapeutics	Current
A novel role for the pol I transcription factor UBF in the regulation of expression of histone gene clusters and cellular DNA damage responses	The Hannan Group - Cancer Therapeutics	Current
Click chemistry enables evaluation of the molecular mechanism of the 2nd generation RNA polymerase I inhibitor, PMR-116	The Hannan Group - Cancer Therapeutics	Current
The contribution of platelets and/or neutrophils to diabetes development	The Simeonovic Group - Diabetes/Transplantation Immunology	Current
NET and histone-mediated damage of insulin-producing islet beta cells	The Simeonovic Group - Diabetes/Transplantation Immunology	Current
The role of heparanase in Type 1 diabetes	The Simeonovic Group - Diabetes/Transplantation Immunology	Current
Regulation of amino acids in the brain	The Billups Group - Synaptic Mechanisms	Potential
Glial modulation of neuronal activity	The Billups Group - Synaptic Mechanisms	Potential
Glutamate recycling at synapses	The Billups Group - Synaptic Mechanisms	Potential
Identification and analysis of platelet polymorphisms associated with malaria susceptibility	The McMorran Group - Genetics and Infectious Diseases	Potential
Studying the interaction between genes and environment in Indigenous Kidney Disease	The McMorran Group - Genetics and Infectious Diseases	Potential
Synthetic platelet microbicidal peptides as novel anti-malarial drugs	The McMorran Group - Genetics and Infectious Diseases	Potential